The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP.
about
Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.Neural differentiation potential of human bone marrow-derived mesenchymal stromal cells: misleading marker gene expression.Influences of polymorphic variants of DRD2 and SLC6A3 genes, and their combinations on smoking in Polish populationBehavioral and Neural Manifestations of Reward Memory in Carriers of Low-Expressing versus High-Expressing Genetic Variants of the Dopamine D2 Receptor.Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans.Two functional serotonin polymorphisms moderate the effect of food reinforcement on BMI.Genospirituality: Our Beliefs, Our Genomes, and Addictions.Association of a missense change in the D2 dopamine receptor with myoclonus dystonia.Valenced action/inhibition learning in humans is modulated by a genetic variant linked to dopamine D2 receptor expressionD1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells.Haplotype diversity and linkage disequilibrium at the DRD2 locus among the tribes of western and southern regions of India.The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery.Variation in the oxytocin receptor gene (OXTR) is associated with differences in moral judgmentSuicidal behavior and haplotypes of the dopamine receptor gene (DRD2) and ANKK1 gene polymorphisms in patients with alcohol dependence--preliminary reportType-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells.Parent-child concordance of Taq1 A1 allele predicts similarity of parent-child weight loss in behavioral family-based treatment programsGenetic approaches to understanding post-traumatic stress disorder.PharmGKB summary: dopamine receptor D2Association of dopamine receptor gene polymorphism and psychological personality traits in liability for opioid addiction.Localization of an ataxia-telangiectasia locus to a 3-cM interval on chromosome 11q23: linkage analysis of 111 families by an international consortium.Neuropharmacology of dopamine receptors:: Implications in neuropsychiatric diseasesChromosomal aberrations and schizophrenia. Autosomes.An association study of DRD2 and COMT polymorphisms with novelty seeking and harm avoidance scores, in two independent samples of depressed patients.Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction.Dopaminergic mutations: within-family association and linkage in multiplex alcohol dependence families.An Alu polymorphism intragenic to the TP53 gene.A new TaqI RFLP within intron 2 of human dopamine D2 receptor gene (DRD2)Fine mapping of the chromosome 11q22-23 region using PFGE, linkage and haplotype analysis; localization of the gene for ataxia telangiectasia to a 5cM region flanked by NCAM/DRD2 and STMY/CJ52.75, phi 2.22A gene x gene interaction between DRD2 and DRD4 is associated with conduct disorder and antisocial behavior in malesDRD2 and PPP1R1B (DARPP-32) polymorphisms independently confer increased risk for autism spectrum disorders and additively predict affected status in male-only affected sib-pair families.Food reinforcement, the dopamine D2 receptor genotype, and energy intake in obese and nonobese humansNeurogenetic Impairments of Brain Reward Circuitry Links to Reward Deficiency Syndrome (RDS): Potential Nutrigenomic Induced Dopaminergic Activation.Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical UtilityAssociation of dopamine receptor gene polymorphisms with the clinical course of Wilson disease.Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).Genetic distribution and association analysis of DRD2 gene polymorphisms with major depressive disorder in the Chinese Han population.Motivational salience and genetic variability of dopamine D2 receptor expression interact in the modulation of interference processingThe D2 dopamine receptor gene and nicotine dependence among bladder cancer patients and controlsRelationship among methadone dose, polymorphisms of dopamine D2 receptor and tri-dimensional personality questionnaire in heroin-addicted patientsSchizophrenia-associated chromosome 11q21 translocation: identification of flanking markers and development of chromosome 11q fragment hybrids as cloning and mapping resources.
P2860
Q30413183-E75DF2FF-F157-48B7-A689-9AB33F270721Q33414415-9B841F02-DAB1-4BCC-B4A6-6F96DDC9AFD4Q33504408-49FE702F-646F-4D26-8BCF-31B918F0C77FQ33619368-4EBE311F-7A22-4B81-B4A9-E2E2144E1462Q33671613-75C6BB35-A650-4C8B-B54C-41D30E8F9F27Q33726497-3F8716F5-C70A-4FD2-9002-204DEA48F79CQ33796498-9E64EF65-2B59-40C4-BBBF-892323DC57DFQ33860047-8762CA37-73D9-40D8-8BB7-D71D91AAF30EQ34010238-AB3832A1-D71F-4796-8A93-5C5194A10497Q34094439-33D0D84D-540A-46D5-A9D9-391A4EDCCC70Q34204822-624FBB6D-161D-4E76-A915-8F85CA646F1DQ34490946-1F4B189D-8AFF-41EB-BAAB-13BD7B5405D4Q34536613-1B8CA509-F3AB-4CA6-AE3C-231410813361Q34557033-388D7B88-E2E9-424E-8569-D95C57502E3CQ34571086-1A3D1F41-1840-48D4-A540-D5A9F9193171Q34626703-75BB8CB2-DDC1-4B0D-975E-8054F99B8E4EQ34940724-2D1DC3CF-4E32-4C7E-A101-AF3238CCF27EQ34970259-21196112-DD9F-49BF-92CE-775BCC4BF32CQ35099937-416C1C34-1E3E-4900-86A1-609E1540C629Q35204529-A4584F93-B202-473B-8B49-10590BC7B33DQ35217260-62D7F589-0E93-4A51-B41D-40E40FEAD67AQ35281112-6116910E-7A65-4E85-AC72-9BC40A6CD602Q35606447-C9A93016-189E-402D-99E6-CE6B9829D024Q35684332-17089B3C-F203-4D7E-90AF-DB64B07F4840Q35760941-A53336A0-44A5-4B47-8110-083312D508B2Q35802335-5099429C-CB02-4FF0-85BF-98355857212AQ35802367-673151C8-7B19-4393-AA3D-276DF3BB0046Q35853237-85D14015-B0DF-4A20-8637-B1C900A30169Q35880389-A359162F-AE06-42AD-AD5D-3F5829178889Q36342328-4880E405-7A7E-4CFE-A5FC-705C56C5787EQ36405184-1AC50B49-5742-46D3-A76F-0F3CA3B4B899Q36476979-321E0485-3412-4C13-9A2A-A40B0A02921EQ36482731-36392D85-F5DF-4B68-984D-8DE62A701A17Q36590927-7F8A8DBE-0EF1-415E-9F77-49BE5F6C0E03Q36849881-D005AC89-8FDF-4A21-938C-0AEA9E40B997Q36853446-CD2F520B-077E-45FD-979E-AFD49342717EQ36903008-8EFBE32E-BF6E-463F-9112-FD9A3381A3A8Q37037238-1596765C-AE3D-466C-809D-A4D68BDA5E0EQ37223916-F6BC7BF8-4B23-4768-A605-4708BAD118F5Q38512882-BDC6BE63-18AD-445B-A098-A529F375BCB0
P2860
The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
The human dopamine D2 receptor ...... 23 and identifies a TaqI RFLP.
@en
type
label
The human dopamine D2 receptor ...... 23 and identifies a TaqI RFLP.
@en
prefLabel
The human dopamine D2 receptor ...... 23 and identifies a TaqI RFLP.
@en
P2093
P2860
P1476
The human dopamine D2 receptor ...... 23 and identifies a TaqI RFLP.
@en
P2093
D K Grandy
J R Bunzow
M Marchionni
R E Magenis
P2860
P304
P407
P577
1989-11-01T00:00:00Z